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Accurate selection of amino acids is essential for faithful transla-
tion of the genetic code. Errors during amino acid selection are
usually corrected by the editing activity of aminoacyl-tRNA syn-
thetases such as phenylalanyl-tRNA synthetases (PheRS), which
edit misactivated tyrosine. Comparison of cytosolic and mitochon-
drial PheRS from the yeast Saccharomyces cerevisiae suggested that
the organellar protein might lack the editing activity. Yeast cytoso-
lic PheRS was found to contain an editing site, which upon disrup-
tion abolished both cis and trans editing of Tyr-tRNAPhe.Wild-type
mitochondrial PheRS lacked cis and trans editing and could synthe-
size Tyr-tRNAPhe, an activity enhanced in active site variants with
improved tyrosine recognition. Possible trans editing was investi-
gated in isolated mitochondrial extracts, but no such activity was
detected. These data indicate that the mitochondrial protein syn-
thesismachinery lacks the tyrosine proofreading activity character-
istic of cytosolic translation. This difference between themitochon-
dria and the cytosol suggests that either organellar protein synthesis
quality control is focused on another step or that translation in this
compartment is inherently less accurate than in the cytosol.
The aminoacyl-tRNA synthetases (aaRS)2 are a ubiquitous and essen-
tial protein family required for protein synthesis (1–3). Structurally and
functionally the aaRSs are divided into two unrelated but biochemically
analogous groups, class I and class II (4–6). The aaRSs attach amino
acids to the 3-ends of tRNA containing the corresponding anticodon
sequence, and the resulting aminoacyl-tRNAs (aa-tRNAs) are used as
substrates for ribosomal translation of mRNA. The accuracy of
aa-tRNA synthesis is generally assured by the existence of aaRSs specific
for each particular amino acid-tRNA pair. Cognate tRNA recognition
and discrimination of non-cognate RNAs are achieved by sequence-
specific direct and indirect readout of the numerous combinations of
bases present in tRNAs (7–10). The relative structural simplicity and
inherent similarity between the amino acid substratesmakes their accu-
rate recognition and discrimination more challenging. Although some
amino acids such as cysteine and tyrosine are different enough to allow
their specific recognition by a particular aaRS (11, 12), others such as
valine and isoleucine are less easily distinguished. For example the class
I aaRS isoleucyl-tRNA synthetase (IleRS) is only able to poorly discrim-
inate against valine, which has a misactivation rate of about 1:200 com-
pared with the cognate substrate isoleucine. Despite this significant rate
of misactivation and misaminoacylation, the accuracy of translation is
not compromised because of the existence of an intrinsic proofreading
and editing mechanism in IleRS that specifically hydrolyzes both mis-
activatedVal-AMPandmisaminoacylatedVal-tRNAIle (13, 14). In addi-
tion to IleRS,many other class I and class II aaRSs also employ editing to
prevent release of non-cognate aa-tRNA and subsequent loss of trans-
lational accuracy (reviewed in Refs. 15 and 16). With a few notable
exceptions (17), editing generally occurs in specialized domains distal
from the active site such as the class I-specific CP1 region of IleRS and
leucyl-, and valyl-tRNA synthetases. The editing domains of class II
aaRSs are more diverse than their class I counterparts and include the
“HXXXH” domain found in both alanyl- (18) and threonyl-tRNA syn-
thetases (ThrRS) (19), an unrelated domain in archaeal ThrRS (20, 21),
the Ybak-like domain in prolyl-tRNA synthetase (ProRS) (22–24), and
the B3/B4 domain of phenylalanyl-tRNA synthetase (PheRS) (25).
The editing domains of aaRSs are normally found in the same subunit
as the active site, the only known exceptions being PheRS and certain
examples of ProRS and ThrRS. PheRS is normally an ()2 heterotet-
ramer, with the active site located in the -subunit and tRNA binding
sites in both subunits. Recent studies in bacteria revealed that hydrolysis
of misaminoacylated Tyr-tRNAPhe occurs at an editing site in the
-subunit 40 Å from the active site (25). This editing site, at the
boundary of the B3 and B4 subdomains, is highly conserved in bacterial
PheRSs and aligns with a divergent domain conserved in eukaryotic and
archaeal sequences that is believed to participate in proofreading. It is
less clear whether mitochondrial PheRSs also have the potential to edit
misacylated tRNAs, as they are monomers and thus lack the conven-
tional ()2 oligomeric form (26, 27). Mitochondrial PheRS sequences
are most closely related to the bacterial type, being chimeras of the
-subunit (with an insertion between motifs 2 and 3) and the C-termi-
nal tRNA anticodon binding domain (B8) of the -subunit (26). Despite
their similarity to bacterial PheRSs, the mitochondrial versions do not
contain regions analogous to the known editing domain (25). Although
it was originally suggested that mitochondrial PheRSs were active in
editing (28), later studies questioned the purity of the enzymes used for
these studies (26). Herewe describe an investigation of amino acid spec-
ificity and editing bymitochondrial and cytosolic PheRSs from the yeast
Saccharomyces cerevisiae. Both enzymes display a lack of specificity
toward Phe and are able to bind Tyr. The cytosolic enzyme is shown to
be less specific than its mitochondrial counterpart but contains an edit-
ing site in the-subunit that specifically editsmisacylatedTyr-tRNAPhe.
The mitochondrial enzyme is deprived of such an activity and is also
able to synthesize the misaminoacylated species Tyr-tRNAPhe. Editing
activity towardTyr-tRNAPhe is also absent frommitochondrial extracts,
indicating the lack of this quality control step in vivo. These findings are
discussed in the context of other recent studies, which together with the
data presented here, raise the possibility that mitochondrial protein
synthesis may be less accurate than its cytosolic counterpart.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, andGeneralMethods—Plasmids carrying cytoso-
lic or mitochondrial yeast tRNAPhe genes for T7 runoff transcription
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were gifts from O. Uhlenbeck (Northwestern University). The
strains Escherichia coli XL1-Blue/pQE31-FRS-ec (producing His6-
tagged E. coli PheRS) and E. coli BL21/pQE32-FRS-sc (producing
His6-tagged cytosolic S. cerevisiae PheRS) were gifts from D. A. Tir-
rell (California Institute of Technology). E. coli BL21-RIL/pET16b
producing His6-tagged mitochondrial S. cerevisiae PheRS was a gift
from R. A. Zimmermann (University of Massachusetts). All His6-
tagged proteins were purified to 99% purity on nickel-nitrilotriace-
tic acid-agarose (Qiagen) by standard procedures. The specific activ-
ities of the purified proteins (nmol of Phe attached/mg/min) were:
wild-type cytoplasmic PheRS, 22; D243A cytoplasmic PheRS, 12;
wild-type mitochondrial PheRS, 89; and A333G mitochondrial
PheRS, 73. Point mutations were introduced into the pheST genes
(encoding the PheRS - and -subunits, respectively) by PCR with
two self-complementary 33-mer oligonucleotides that carried the
appropriate mutations. Reactions were performed with the
QuikChange site-directed mutagenesis kit (Stratagene). Introduc-
tion of the desired mutations was monitored by sequencing of the
resulting genes. Commercial L-Tyr (Sigma) was shown to be free of
phenylalanine (Phe) contamination by pyrophosphate exchange
before and after recrystallization of the amino acid as described previ-
ously (29). LB andM9mediawere prepared as described previously (30).
All buffers were adjusted to the correct pHwithNaOHunless otherwise
indicated. Immunoblotting was performed as described previously (31)
using rabbit polyclonal antibodies raised against yeast cytosolic PheRS
(AnimalPharm, Healdsburg, CA). tRNATrp and tryptophanyl-tRNA
synthetase were prepared as described previously (31).
Preparation of in Vitro Transcribed tRNAPhe—In vitro T7 RNA
polymerase runoff transcription reactions were conducted according to
standard procedures (32). After ethanol precipitation, tRNA transcripts
were resuspended by heating in 10 mM Hepes (pH 7.2), 1 mM EDTA,
and 7 M urea, loaded on a Resource Q 6 anion exchange column (Amer-
sham Biosciences) and eluted with a gradient of 0–1 M NaCl in the
loading buffer. Fractions containing tRNAwere pooled and desalted on
a PD-10 column (Amersham Biosciences) against 10 mM Hepes (pH
7.2). The transcripts were ethanol precipitated, washed with 80% etha-
nol, dried, resuspended in 10 mM Hepes, pH 7.2, and 2 mM MgCl2, and
finally refolded by incubation for 1min at 75 °C followed by slow cooling
down to room temperature.
ATP-PPi Exchange Reaction—The reaction was carried out at 37 °C
in amedium containing 100mMNa-Hepes (pH 7.2), 30mMKCl, 10mM
MgCl2, 2 mM NaF, 2 mM ATP, 2 mM [32P]PPi (1 cpm/pmol), various
amounts of Phe (1.5–300M) andTyr (0.2 to 7mM), and 13 nM cytosolic
PheRS or 10–70 nMmitochondrial enzyme. After 1–5 min, 25 l of the
reaction were removed and added to a solution containing 1% charcoal,
5.6% HClO4, and 75 mM PPi. The radiolabeled ATP bound to the char-
coal was filtered through a 3MM Whatman filter disc under vacuum
andwashed three timeswith 5ml ofwater and oncewith 5ml of ethanol.
The filters were dried, and the radioactivity was counted by liquid scin-
tillation counting (Ultima Gold, Packard Instrument Co.).
Aminoacylation Assay with Radiolabeled Amino Acids—Aminoacy-
lation was performed in 100 mM Na-Hepes (pH 7.2), 30 mM KCl, 2 mM
ATP, 10 mM MgCl2, 25 M L-[14C]Phe (280 cpm/pmol), 5 M tRNA
transcript, and 10–100 nM yeast PheRS. 15-l aliquots were spotted on
3MM filter disks (Whatman), washed three times in 10% trichloroacetic
acid, and dried. The amount of radioactivity retainedwas determined by
liquid scintillation counting. One unit of PheRS corresponded to the
amount of enzyme necessary to catalyze the formation of 1 nmol of
Phe-tRNAPhe min1 mg1 protein at 37 °C.
Aminoacylation Assay with Radiolabeled tRNA—Synthesis of tRNA
32P-labeled pA76 transcripts were performed essentially as described
previously (33) except that the CCA-3-end was removed prior to label-
ing. Briefly, the CCA-3-terminal nucleotides of the tRNA were first
removed by treatment of 20 M tRNA transcript with 73 g/ml Crota-
lus atrox venom (Sigma) in a buffer containing 40 mM sodium Gly (pH
9.0) and 10 mM magnesium acetate. The mix was incubated for 2 h at
21 °C and phenol/chloroform extracted and ethanol precipitated and
finally desalted by gel filtration through a Sephadex G 25 column
(Amersham Biosciences). The CCA-3-end of the tRNA was reconsti-
tuted and radiolabeled by incubation for 10 min at 37 °C with 0.5 M
snake venom-treated tRNA in 50mMNa-Gly (pH9.0), 10mMMgCl2, 10
M CTP, 9 M ATP, 1 M [-32P]ATP with 3 g/ml E. coli tRNA-
terminal nucleotidyltransferase (34) in a final volume of 20 l. The
reaction was stopped by the addition of 1 volume of phenol, and the
resulting mixture was gel filtered twice through a G25 column. As
described previously (33), the aminoacylation reaction was performed
in a 10-l aminoacylation medium (see above) containing 5 mM cold
amino acids or Phe analogues, 5 M transcript, and a trace of radiola-
beled tRNA. After 15 min of incubation an aliquot was removed and
incubated for 30min at room temperaturewith P1 RNase. The liberated
[-32P]AMP and aminoacyl-[-32P]AMP were separated by TLC on
polyethyleneimine cellulose and visualized as described previously (33).
Post-transfer Editing Assay—The cytosolic or mitochondrial Tyr-
tRNAPhe and Phe-tRNAPhe (S. cerevisiae transcripts) were prepared as
described previously (25) in an aminoacylation reaction containing 30
M [3H]Tyr (180 cpm/pmol), 0.5 Mmitochondrial PheRS A333G, and
5 M corresponding in vitro transcribed tRNAPhe. Comparison to the
total tRNA concentration then allowed us to estimate that purified Phe-
tRNAPhe yields were about 20% (i.e. these preparations also contained
80% uncharged tRNA), whereas Tyr-tRNAPhe yields were 15% (85%
uncharged), within the typical range expected for aminoacyl-tRNA
preparations. Post-transfer editing reactionmixtures contained 100mM
Na-Hepes (pH 7.2), 30 mM KCl, 10 mMMgCl2, 1 M [3H]Tyr-tRNAPhe,
and a catalytic amount of PheRS (5 nM cytosolic or 5 nM to 2 M mito-
chondrial yeast PheRS). The mixture was incubated at 37 °C, and the
post-transfer editing reaction was followed bymeasuring the remaining
radiolabeled aa-tRNA in aliquots of 15 l after 0–12 min of incubation
as described for the aminoacylation assay (see above). The amount of
cytosolic or mitochondrial crude extract from S. cerevisiae used in the
editing assay was determined according to the PheRS specific activity
measured for the extracts, 0.78 nmol/min/mg of protein and 0.19 nmol/
min/mg of protein, respectively.
Preparation of Cytosolic and Mitochondrial Fractions of S. cerevisiae—
S. cerevisiae strainW303 was grown in rich medium containing 2% galac-
tose, andmitochondria were isolated as described previously (35). Sphero-
plasts were prepared by Zymolyase-20T (ICN) treatment and broken by
three passes through an EmulsiFlex®-C5 (AVESTIN) in 0.6 M sorbitol
(Fluka), 10mMTris-HCl (pH7.4), and1mMphenylmethylsulfonyl fluoride.
Mitochondriawere purified by centrifugation and extensivewashing in the
same buffer as described previously (36). The cytosolic fraction obtained
during this procedure was clarified by ultracentrifugation at 100,000  g.
Highly purified organelles were obtained by centrifugation at 100,000  g
(Beckman SW41) in a PercollTM step gradient (Amersham Biosciences)
(40%PercollTM in 0.6M sorbitol (Fluka), 10mMTris-HCl (pH7.4), overlaid
with 20%PercollTM in the samebuffer). These procedures yielded cytosolic
and mitochondrial fractions with less than 0.5% cross-contamination as
judged byWestern blot analysis with antibodies specific for proteins in the
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different compartments as described elsewhere (37). Mitochondria were
suspended in aminoacylation buffer (see above) followed by sonication for
1min at 50% output with a Sonifier 450 (Branson) equipped with amicro-
probe.The resulting extractwas centrifuged at 100,000 g for 1h (S100) to
precipitate the membrane fractions. The resulting soluble extracts were
used for aminoacylation assays.
Phylogenetic Analyses—179 PheRS -subunit sequences (92 from
eubacteria, 23 from archaea, and 35 and 29 cytosolic andmitochondrial
eukaryotic sequences, respectively) were aligned with the ClustalX pro-
gram version 1.83 (38). The alignment process was guided with the
known three-dimensional structure of PheRS of Thermus thermophilus
and refined manually. The trees were generated by applying the neigh-
bor-joining method with the program ClustalX or the Phylip package
version 6.63 (39) to a set of 100 bootstrap replicates of the ungapped
alignment. Maximum likelihood analysis was also applied to the same
alignment with the program Puzzle version 5.2 (40) where more than
50  106 quartets were analyzed. The trees were rooted using the nine
known sequences of o-phosphoseryl-tRNA synthetase found in metha-
nogenic archaea that were previously identified as paralogues of the
-subunit of PheRS (41).
RESULTS
The -Subunit of Cytosolic PheRS Contains a Post-transfer Editing
Site—Previous studies (42, 43) suggested that yeast cytosolic PheRS
could hydrolyze Tyr-tRNAPhe, as recently directly demonstrated for the
E. coli enzyme (25). Tyr-tRNAPhe was synthesized and added to a deacy-
lation reaction containing yeast cytosolic PheRS. Cytosolic PheRS was
able to specifically deacylate Tyr-tRNAPhe derived from both cytosolic
and mitochondrial tRNAs, indicating the presence of trans editing
activity (Fig. 1). Amino acid sequences from 179 PheRSs were aligned to
investigate whether this activity in the yeast enzyme could be attributed
to a catalytic site in the-subunit, as is the case inE. coli. Examination of
the PheRS -subunit sequence alignment allowed identification of
domains B1, B3, and B4 (B2 is absent from eukaryotes), but B3/B4 res-
idues which are involved in bacterial editing were not well conserved in
their eukaryotic counterparts (Fig. 2). The average percentage amino
acid identities observed within eubacterial and eukaryotic B3/B4
ungapped domain alignments were 42 and 57%, respectively, whereas
there was far less similarity when eukaryotic and eubacterial B3/B4
domains were compared with each other (15% identity). No conserva-
tion was seen at the small residues Thr354 and Ala356, changes in which
ablated editing byE. coli PheRS.Moderate conservationwas observed at
His265 and Glu334 (His158 and Asp243, respectively, in yeast PheRS) sug-
gesting that those residuesmight contribute to the editing activity of the
cytosolic enzyme. Based on this analysis, cytosolic PheRS variants were
produced containing the replacements H158A and D243A.
Although the H158A replacement had no effect (data not shown),
introduction of D243A led to a loss in Tyr-tRNAPhe deacylation activ-
ity (Fig. 3A) similar to that observed for E. coli variants defective in
editing (25). The loss of editing but not synthetic activity resulting from
the D243A replacement was confirmed by the ability of this PheRS
variant to synthesize Tyr-tRNAPhe (Fig. 3B). The misaminoacylation
activity of PheRS D243A was specific for yeast cytosolic tRNAPhe, as
mitochondrial tRNAPhe was not a substrate for tyrosylation. This con-
firms previous indications that mitochondrial tRNAPhe could not be
phenylalanylated by cytosolic PheRS (Fig. 3C). This discrepancy
between the aminoacylation and editing capacities of mitochondrial
tRNAPhe, together with the absence of an obvious editing domain,
prompted us to investigate the organellar PheRS in more detail.
FIGURE 1. Specific deacylation of Tyr-tRNAPhe by yeast cytosolic PheRS. Reactions
were performed with 1 M Tyr-tRNAPhe prepared from in vitro transcribed yeast cytosolic
tRNAPhe (circles) or yeast mitochondrial tRNAPhe (triangles) with the addition of 5 nM
cytosolic PheRS (filled symbols) or in the absence of enzyme (open symbols). Values
shown are the means of three independent experiments, with error bars representing 
1 S.D. The possible contribution of nonspecific nuclease activity to the observed deacy-
lation was excluded by the finding that cytosolic PheRS did not significantly deacylate
Phe-tRNAPhe after its synthesis (see for example Fig. 3C).
FIGURE 2. Comparison of the -subunits of
eubacterial and eukaryotic PheRSs. A, modular
structure of the PheRS -subunit. B, sampling of an
alignment of the B3/B4 domain regions. Positions
previously identified as being involved in the edit-
ing activity of E. coli PheRS are indicated with black
arrows. The equivalent positions found in the
yeast -subunit are indicated with white arrows.
The sequence alignment (44 eubacterial and 44
eukaryotic sequences) was shaded with the pro-
gram Bioedit. Gray boxes indicate 60% conserva-
tion according to similarity matrix (PAM250)-
based shading. Black boxes indicate residues
identical in more than 60% of the sequences.
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Selectivity of the Active Sites of Mitochondrial and Cytosolic PheRS—
The specificity of the active sites of both yeast PheRSs toward Phe and
Tyr was investigated by determining the catalytic constants for steady-
state amino acid activation from ATP-PPi exchange kinetics (TABLE
ONE). Themitochondrial PheRS was four timesmore efficient than the
cytosolic PheRSwith respect to Phe activation. This wasmostly because
of the 7-fold weaker apparent affinity of the cytosolic enzyme for its
substrate compared with themitochondrial enzyme. This tendency was
reversed when Tyr was the substrate. Because Tyr exhibits poor solu-
bility wewere unable to saturate themitochondrial enzyme. Instead, the
kcat/Km was estimated at sub-saturating concentrations of Tyr.
Although the cytosolic enzyme was twice as efficient for Tyr activation
as its mitochondrial counterpart, for both enzymes the relative effi-
ciency of activation of Phe was only 1–2 orders of magnitude higher
than forTyr. To determinewhether such a poor apparent selectivitywas
because of the contamination of Tyr by a trace of Phe we assessed the
purity of theTyr substrate bymass spectrometry (data not shown). Even
after several cycles of heating and cooling, the Tyr used for our experi-
ments was found to be stable and free of any trace of Phe.
Specificity of Yeast Cytosolic PheRS Editing—To further define the
specificity of the editing reaction several amino acids and Phe analogues
were tested for their ability to be attached to tRNAPhe by cytosolic
PheRS and the editing-defective variant D243A. The compounds used
were the 20 canonical amino acids, three intermediates of Phe metabo-
lism (phenylpyruvate, p-hydroxyphenylpyruvate, and prephenate), and
four other Phe analogues (p-fluoro, p-chloro, p-bromo-, and p-amino-
Phe) that are known to be charged but not edited by E. coli PheRS (25).
In addition to Phe, para-halogenated Phe derivatives, p-amino-Phe,
Leu, and Trpwere attached to tRNAby both enzymes indicating that all
were substrates for the synthetic site of the -subunit but not for the
editing site of the -subunit (Fig. 4A). In the case of Trp, this supports
previous data from in vivo misincorporation experiments (44). The
D243A variant also synthesized Tyr-tRNAPhe indicating that this par-
ticular aminoacyl group is recognized by both the synthetic and editing
sites of PheRS (Fig. 4B).
Mitochondrial PheRS Lacks the Capacity to EditMischarged tRNAPhe—
To test the capacity of yeast mitochondrial PheRS to edit misaminoacy-
lated products, Tyr-tRNAPhe was incubated with the enzyme under
conditions previously used tomonitor the same activity in bacterial and
cytosolic enzymes. No significant hydrolysis of Tyr-tRNAPhe was
observed in the presence of excess enzyme, the rate of deacylation being
comparable with that seen in the absence of PheRS (Fig. 5A). These data
showed that yeast mitochondrial PheRS, in contrast to its cytosolic
counterpart, was unable to trans edit exogenous Tyr-tRNAPhe. To
probe the possibilities that mitochondrial PheRS either edits solely at
the pretransfer step or that it edits Tyr-tRNAPhe only in cis (i.e.when still
bound to PheRS), we attempted to tyrosylate tRNAPhe with the wild-
type enzyme.Wild-typemitochondrial PheRSwas able to stably synthe-
size Tyr-tRNAPhe, suggesting the absence of effective editing mecha-
nisms in this enzyme (Fig. 5B). To investigate whether mitochondrial
PheRS contains a low level of cis editing activity not readily detectable
under the standard assay conditions, the amino acid binding pocket was
enlarged to better accommodate tyrosine as described previously (45)
for the E. coli enzyme. The resulting variant, mitochondrial PheRS
A333G, showed considerably improved Tyr-tRNAPhe synthesis com-
pared with the wild type providing further evidence that the organellar
protein lacks editing activity (Fig. 5B). We also attempted to monitor
pretransfer editing as described previously (25) for the E. coli enzyme
but were unable to detect any significant activity for either the cytosolic
or mitochondrial enzymes (data not shown).
Trans Editing of Tyr-tRNAPhe Is Confined to Cytosolic Protein Synthe-
sis in Yeast—Although our in vitro studies showed that mitochondrial
PheRS could not edit Tyr-tRNAPhe, it is possible that other factorsmight
act in trans after dissociation of the non-cognate aa-tRNA from the
enzyme. Such factors could include specific trans editing enzymes (24,
46) or cytosolic PheRS imported into yeast mitochondria as described
for other aaRSs (37). Yeast mitochondrial and cytosolic fractions were
purified as described previously (37), and the localization of PheRS was
examined in each compartment by immunoblotting (Fig. 6A). Cytosolic
PheRS was not detectable in mitochondrial extracts, suggesting that
trans editing by imported -subunits would not compensate for the
absence of editing activity in themitochondrial enzyme. The amount of
each subcellular fraction required to aminoacylate comparable amounts
of tRNAPhe with Phe was quantified (Fig. 6B), and based upon these
measurements comparable phenylalanylation activities were then incu-
FIGURE 3. Disruption of post-transfer editing by yeast cytosolic PheRS. A, post-trans-
fer editing of Tyr-tRNAPhe by wild-type and variant PheRSs. Reactions were performed
with 1 M cytosolic Tyr-tRNAPhe in the presence of 5 nM enzyme. B, tyrosylation of
tRNAPhe by cytosolic PheRS. Reactions were performed with 10 M cytosolic tRNA or 3.5
M mitochondrial tRNA and 0.1 M PheRS. C, phenylalanylation of mitochondrial
tRNAPhe. Reactions were performed with 3.5 M in vitro transcribed tRNAPhe and 0.1 M
PheRS. Circle, wild-type cytosolic PheRS; triangle, editing-defective (D243A) cytosolic
PheRS; square, mitochondrial PheRS; diamond, without enzyme; filled symbols, cytosolic
tRNA; open symbols, mitochondrial tRNA.
Loss of Editing from Mitochondrial PheRS
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bated with different Tyr-tRNAPhe species and the rate of deacylation
monitored (Fig. 6C). The cytosolic fraction was able to rapidly deacylate
Tyr-tRNAPhe, whereas the mitochondrial extract showed no significant
difference in the rates of deacylation of Phe-tRNAPhe and Tyr-tRNAPhe.
These findings were in agreement with the in vitro data described above
and supported the notion that Tyr-tRNAPhe is not subject to proofread-
ing and editing in yeast mitochondria.
Phylogenetic Analysis of PheRS—Phylogenetic trees were calculated
using two neighbor-joining methods and a character-based maximum
likelihood method and rooted with an alignment of o-phosphoseryl-
tRNA synthetase sequences. All trees exhibited the same overall topol-
ogy (Fig. 7), with the mitochondrial/eubacterial sequences forming one
major cluster and archaeal/eukaryotic sequences the other. In agree-
mentwith previous reports (47, 48), the only exceptionswere spirochete
PheRS sequences, which clustered with the archaea, and mycoplas-
mataceae PheRS sequences, which clustered with the mitochondria.
DISCUSSION
Yeast Mitochondrial PheRS Is an Error-prone Enzyme—Previous
studies (26) have shown that although the two PheRSs of yeast differ
significantly in their tertiary and quaternary structures, they share sim-
ilar kinetic parameters for cognate aminoacylation and are thus func-
tionally analogous. The most significant difference between the cytoso-
lic and mitochondrial versions of human PheRS is a lower apparent
affinity for tRNA in the organellar enzyme (27). High-resolution crystal
structures suggested that the substantial differences between the
canonical ()2 PheRS and the mitochondrial -type might not signif-
icantly impact tRNA aminoacylation, as the additional domains in the
former were presumed to have alternative non-canonical functions. For
example, the helix-turn-helix motif in domain B5 was shown to be a
bona fide DNA binding motif in T. thermophilus PheRS, capable of
binding looped double-stranded DNA (49). Deletion and mutagenesis
of B5 and other domains did not abolish the canonical activity of PheRS,
leading to the conclusion that domains 1–5 of the-subunit are dispen-
sable for efficient aminoacylation (50). One notable exception is the
B3/B4 editing domain, which is required in vitro and in vivo for the
hydrolysis of non-cognate Tyr-tRNAPhe synthesized by PheRS. No
region homologous to B3/B4 is detectable at the amino acid sequence
level in mitochondrial PheRS, and the studies described here show that
this correlates with a lack of editing activity in the enzyme. Comparison
TABLE ONE
Steady-state kinetic constants for ATP-[32P]PPi exchange for cytosolic and mitochondrial PheRS from yeast
PheRS
Phe Tyr Selectivity
(kcat/KM)Phe/
(kcat/KM)TyrKM kcat kcat/KM KM kcat kcat/KM
M s1 s1 M1 M s1 s1 M1
Cytosol 30  2 240  40 8  2 860  300 160  40 0.2  0.1 40  30
Mitochondria 4.2  0.1 150  5 40  2 (1700)a (150)a 0.09  0.01b 400  80
a Lower limits based on the assumption that the mitochondrial enzyme, like the cytoplasmic enzyme, has similar kcat values for Tyr and Phe.
b Due to the high KM compared to practical Tyr concentrations ([S]KM), kcat/KM was directly estimated from the equation v  kcat/KM ([E][S]).
FIGURE 4. Substrate specificity of editing by yeast cytosolic PheRS. TLC analysis of the
aminoacylation of tRNAPhe with various amino acids and Phe analogues by the wild-type
cytosolic PheRS (A) and the editing-defective variant D243A PheRS (B). TLC analysis of
the aminoacylation of tRNATrp with Trp by tryptophanyl-tRNA synthetase (C). No aa, no
amino acid.
FIGURE 5. Non-cognate aminoacylation by yeast mitochondrial PheRS. A, deacyla-
tion of Tyr-tRNAPhe. Tyr-tRNAPhe was prepared using in vitro transcribed yeast mitochon-
drial tRNAPhe and incubated in the presence of 1 M (●) yeast mitochondrial PheRS or
without enzyme (). B, aminoacylation of the mitochondrial tRNAPhe transcript (3.5 M)
with Tyr (30 M) by the mitochondrial PheRS (2 M). ●, wild-type mitochondrial PheRS; Œ,
A333G mitochondrial PheRS. The comparatively low final charging level of tRNA (10 –
30%) likely reflects reactions performed at substantially sub-saturating concentrations
of Tyr because of practical considerations.
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of Phe and Tyr activation by the cytosolic and mitochondrial enzymes
showed only modest differences in substrate specificities, indicating
that both enzymes have significant capacities for non-cognate amino-
acylation. Previous studies (51) have shown that Tyr and Phe are likely
present at comparable levels inmitochondria and the cytosol, indicating
that the likelihood of non-cognate amino acid activation by PheRS will
not be affected by subcellular localization. For the cytosolic enzyme, the
existence of an editingmechanism ensures that any errors in amino acid
activation do not affect the overall accuracy of the aminoacylation reac-
tion. No such editing mechanism exists, either in cis or trans, during
mitochondrial phenylalanylation, and the organellar PheRS can be con-
sidered an error-prone enzyme. Other aaRSs, such as certain ProRSs
(46, 52) and ThrRSs (21), have also been shown to have natural uncor-
rected mischarging activities that result in non-cognate aminoacyl-
tRNA synthesis. However, in both cases the enzymes are not considered
error-prone, as they associate with other proteins that ensure non-cog-
nate aminoacyl-tRNAs are rapidly edited (53). Mitochondrial PheRS is
markedly different in that no detectable editing activity is associated
with it, suggesting amino acid specificity was lost during evolution from
more accurate ancestral proteins.
Loss of the Editing Subdomain during Evolution of Mitochondrial
PheRS—Previous analyses (47, 48) based upon alignments of PheRS
-subunit amino acid sequences indicated a canonical phylogeny for
this protein family, with the only significant horizontal gene transfer
being observed in the spirochetes. The updated analysis described here
provides a similar phylogenetic tree composed of monophyletic
archaeal/eukaryotic and bacterial clusters, with the mitochondrial
PheRSs forming a single, distinct subgroup within the latter (Fig. 7).
These data suggest a single bacterial origin for extant mitochondrial
PheRSs but provide few clues on the subsequent evolution of the
organellar protein. The widespread retention of a discrete full-length
-subunit indicates that editing activity was lost after separation of the
mitochondrial proteins. In addition to the absent B3/B4 editingmodule,
mitochondrial PheRSs lack the B5 DNA binding domain, B6/B7 oli-
gomerization domain, and B2 EMAP domain, suggesting that loss of
editing may have been part of a broader process whereby numerous
functions dispensable for protein synthesis were lost during evolution of
the organellar protein. This loss of function is, to date, limited to mito-
chondria, as chloroplast PheRSs are of the ()2 type and contain an
intact B3/B4 domain (54).
Editing of Misacylated tRNAs in Mitochondria—The loss of editing
function from mitochondrial PheRS is particularly striking because it
was accompanied by a significant change in the oligomeric state of the
protein. Less dramatic changes were also shown to lead to a loss of
editing function from human mitochondrial LeuRS, which is able to
stably synthesize Ile-tRNALeu in vitro (55). The editing function of
LeuRS is contained in the highly conservedCP1 domain (56, 57), but key
residues in this region necessary for hydrolysis of non-cognate amino-
acyl-tRNA have diverged during evolution leading to a loss of function
from the mitochondrial protein. Although it is unclear whether other
factors act in trans to compensate for the lack of editing by mitochon-
drial LeuRS, the evolutionary trend toward a more error-prone aaRS
mirrors that described above for PheRS. This, in turn, raises the ques-
tion as to whether othermitochondrial aaRSsmight also lack the capac-
ity to editmisaminoacylated tRNAs. For example,mitochondrial ThrRS
lacks either of themodules known to edit Ser-tRNAThr (19–21) suggest-
ing that this misacylated species might also escape hydrolysis. However,
Ser-tRNAThr can be directly hydrolyzed by free-standing editing
FIGURE 6. Aminoacylation and post-transfer editing by yeast mitochondrial and
cytosolic fractions. A, immunodetection of PheRS in cytosolic and mitochondrial frac-
tions. 20 g of protein from mitochondrial and cytosolic fractions was subjected to
SDS/PAGE, and the PheRSs were subsequently detected by immunoblotting using rab-
bit anti-yeast cytosolic PheRS antibodies. This allowed detection of mitochondrial PheRS
(m) and both subunits of the cytosolic PheRS (c and c) as indicated by the correspond-
ing arrows. Lanes: 1, mitochondrial fraction; 2, cytosolic fraction. B, phenylalanylation
activity. Aminoacylation of the cytosolic tRNAPhe transcript (5 M) was performed with
Phe (30 M) by the mitochondrial (160 g of protein/ml) (Œ) or cytosolic (180 g of
protein/ml) (●) fractions. C, post-transfer editing of Tyr-tRNAPhe. Tyr-tRNAPhe (black) or
Phe-tRNAPhe (gray) was prepared using in vitro transcribed yeast cytosolic or mitochon-
drial tRNAPhe and incubated, respectively, with the same amounts of cytosolic (circles) or
mitochondrial (triangles) crude extracts as used in B.
FIGURE 7. Phylogenetic analysis of PheRS -subunits (A) and comparison of the
organization of eubacterial and mitochondrial PheRS genes (B). Black squares, dark
gray squares, and light gray squares indicate nodes found in 95%, 85%, and 65%,
respectively, of the trees generated by neighbor-joining or maximum likelihood analysis.
A single recombination event (dashed line) involving the eubacterial ,-subunit operon
might be at the origin of the fused , mitochondrial PheRS.
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domains acting in trans emphasizing the need for direct experimental
confirmation that particular editing pathways are absent from
mitochondria.
The absence of certain aaRS editing reactions from mitochondria
suggests that the need for fidelity during aminoacyl-tRNA synthesis
may be lower in this compartment than in the cytosol, perhaps acceler-
ating the loss of these energetically costly secondary activities. Loss of
the editing domain frommitochondrial PheRS is in stark contrast to the
general pattern of synthetase evolution, where modules with new func-
tionality have been systematically integrated into extant proteins (58).
This fundamental difference betweenmitochondrial and cytosolic aaRS
evolution and function indicates that either organellar protein synthesis
quality control is focused on another step or that translation in this
compartment is inherently less accurate. From a physiological stand-
point, reduced accuracy during translation might not be as detrimental
in the mitochondrial system, where only a small number of proteins are
encoded. In the presence of an efficient protein degradationmachinery,
it is not unlikely that the bulk of the mitochondrial quality control
occurs post-translationally at the level of protein stability as has been
recently shown (see for example Ref. 59 and references therein). In this
respect, only folded proteins that can join an active respiratory complex
are protected from degradation. Mistakes in any protein subunit result-
ing from reduced translational accuracy can be easily accommodated by
very rapid protein degradation. This model could be easily re-enforced
by measuring translational accuracy with mitochondrial ribosomes and
comparing the error rate to that of degradation. However, currently in
vitro translation systems with mitochondrial ribosomes have not been
established, and this will thus remain an open question.
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